Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 845 - LEAD POISONING PREVENTION CODE › Subpart B - DEPARTMENT AND DELEGATE AGENCY ACTIVITIES › Section 845.65 - Provision of Data

Current through Register Vol. 48, No. 28, July 12, 2024
a) Only
				aggregated medical data from which it is impossible to identify any patient,
				reporting entity, or primary caregiver, shall be made available via an annual
				lead poisoning surveillance report drafted by the Department.
b) All requests by researchers for
				confidential data shall be submitted in writing to the Department. The request
				shall include a study protocol that contains: objectives of the research;
				rationale for the research, including scientific literature justifying the
				current proposal; overall study methods, including copies of forms,
				questionnaires, and consent forms used to contact facilities, physicians or
				study subjects; methods for documenting compliance with Department of Health
				and Human Services - Protection of Identity - Research Subjects;
				42 CFR 2a.4(a)
				through (j),
				2a.6(a)
				and (b),
				2a.7(a) and
				(b)(1); methods for processing data; storage
				and security measures taken to ensure confidentiality of patient identifying
				information; time frame of the study; a description of the funding source of
				the study (e.g., federal contract); the curriculum vitae of the principal
				investigator; and a list of collaborators. In addition, the research request
				must specify what patient identifying information is needed and how the
				information will be used. Identifying information is defined as any
				information, collection, or groups of data from which the identity of the
				patient or reporting entity to which it relates may be discerned, e.g., name,
				address or ID number.
c) Upon
				request, the Department shall disclose individual patient or reporting entity
				information to the reporting entity that originally supplied that information
				to the Department.
d) By written
				reciprocating agreement, the Department may disclose individual patient
				information concerning residents of another state to the Childhood Lead
				Poisoning Prevention Program in the individual's state of residence only if the
				recipient of the information is legally required to hold the information in
				confidence and provides protection from disclosure of patient identifying
				information equivalent to the protection afforded by the Medical Studies
				Act.
e) The identity of any person
				(or any group of facts that tends to lead to the identity of any person) whose
				blood test result is submitted to the Illinois Childhood Lead Poisoning
				Prevention Program is confidential and shall not be open to public inspection
				or dissemination. This information shall not be available for disclosure,
				inspection or copying under the Freedom of Information Act or the State Records
				Act. All information for specific research purposes may be released in
				accordance with procedures established by the Department in this
				Section.
f) The patient identifying
				information submitted to the Department by those entities required to submit
				information under the Act and this Part is to be used in the course of medical
				study under the Medical Studies Act and is privileged from disclosure by the
				Medical Studies Act.